Life Science Tools Market Size to Hit USD 456.15 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Technology Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Life Science Tools Market, By Product

7.1. Life Science Tools Market, by Product Type
7.1.1. NGS
7.1.1.1. Market Revenue and Forecast
7.1.2. Sanger Sequencing
7.1.2.1. Market Revenue and Forecast
7.1.3. Nucleic Acid Preparation
7.1.3.1. Market Revenue and Forecast
7.1.4. Nucleic Acid Microarray
7.1.4.1. Market Revenue and Forecast
7.1.5. PCR & qPCR
7.1.5.1. Market Revenue and Forecast
7.1.6. Flow Cytometry
7.1.6.1. Market Revenue and Forecast
7.1.7. Mass Spectrometry
7.1.7.1. Market Revenue and Forecast
7.1.8. Separation Technologies
7.1.8.1. Market Revenue and Forecast
7.1.9. Electron Microscopy
7.1.9.1. Market Revenue and Forecast
7.1.10. NMR
7.1.10.1. Market Revenue and Forecast
7.1.11. Others
7.1.11.1. Market Revenue and Forecast

Chapter 8. Global Life Science Tools Market, By End-User

8.1. Life Science Tools Market, by End-User
8.1.1. Biopharmaceutical Company
8.1.1.1. Market Revenue and Forecast
8.1.2. Government & Academic
8.1.2.1. Market Revenue and Forecast
8.1.3. Industry
8.1.3.1. Market Revenue and Forecast
8.1.4. Health Care
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Life Science Tools Market, By Technology

9.1. Life Science Tools Market, by Technology
9.1.1. Genomic Technology
9.1.1.1. Market Revenue and Forecast
9.1.2. Cell Biology Technology
9.1.2.1. Market Revenue and Forecast
9.1.3. Proteomics Technology
9.1.3.1. Market Revenue and Forecast
9.1.4. Lab Supplies & Technologies
9.1.4.1. Market Revenue and Forecast
9.1.5. Other Analytical & Sample Preparation Technology
9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Life Science Tools Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product
10.1.2. Market Revenue and Forecast, by End-User
10.1.3. Market Revenue and Forecast, by Technology
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product
10.1.4.2. Market Revenue and Forecast, by End-User
10.1.4.3. Market Revenue and Forecast, by Technology
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product
10.1.5.2. Market Revenue and Forecast, by End-User
10.1.5.3. Market Revenue and Forecast, by Technology
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product
10.2.2. Market Revenue and Forecast, by End-User
10.2.3. Market Revenue and Forecast, by Technology
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product
10.2.4.2. Market Revenue and Forecast, by End-User
10.2.4.3. Market Revenue and Forecast, by Technology
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product
10.2.5.2. Market Revenue and Forecast, by End-User
10.2.5.3. Market Revenue and Forecast, by Technology
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product
10.2.6.2. Market Revenue and Forecast, by End-User
10.2.6.3. Market Revenue and Forecast, by Technology
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product
10.2.7.2. Market Revenue and Forecast, by End-User
10.2.7.3. Market Revenue and Forecast, by Technology
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product
10.3.2. Market Revenue and Forecast, by End-User
10.3.3. Market Revenue and Forecast, by Technology
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product
10.3.4.2. Market Revenue and Forecast, by End-User
10.3.4.3. Market Revenue and Forecast, by Technology
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product
10.3.5.2. Market Revenue and Forecast, by End-User
10.3.5.3. Market Revenue and Forecast, by Technology
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product
10.3.6.2. Market Revenue and Forecast, by End-User
10.3.6.3. Market Revenue and Forecast, by Technology
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product
10.3.7.2. Market Revenue and Forecast, by End-User
10.3.7.3. Market Revenue and Forecast, by Technology
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product
10.4.2. Market Revenue and Forecast, by End-User
10.4.3. Market Revenue and Forecast, by Technology
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product
10.4.4.2. Market Revenue and Forecast, by End-User
10.4.4.3. Market Revenue and Forecast, by Technology
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product
10.4.5.2. Market Revenue and Forecast, by End-User
10.4.5.3. Market Revenue and Forecast, by Technology
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product
10.4.6.2. Market Revenue and Forecast, by End-User
10.4.6.3. Market Revenue and Forecast, by Technology
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product
10.4.7.2. Market Revenue and Forecast, by End-User
10.4.7.3. Market Revenue and Forecast, by Technology
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product
10.5.2. Market Revenue and Forecast, by End-User
10.5.3. Market Revenue and Forecast, by Technology
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product
10.5.4.2. Market Revenue and Forecast, by End-User
10.5.4.3. Market Revenue and Forecast, by Technology
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product
10.5.5.2. Market Revenue and Forecast, by End-User
10.5.5.3. Market Revenue and Forecast, by Technology

Chapter 11. Company Profiles

11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bruker Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hitachi, Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Illumina, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Oxford Instruments plc
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Qiagen N.V.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Shimadzu Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Thermo Fisher Scientific, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ZEISS International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global life science tools market size is expected to reach over USD 456.15 billion by 2034 from USD 151.62 billion in 2025.

Rapid technological advancements adopted by the companies operating in the life science tools market in the field of sequencing technologies, mass spectrometry, NMR, chromatography methods, and other products significantly drives the market growth.

The global life science tools market is valued at USD 151.62 billion in 2025.

The global life science tools market is poised to grow at a CAGR of 12.85% over forecast period 2025 to 2034.

In terms of revenue, North America accounted for the maximum revenue share in 2024 due to local presence of major market leaders such as Thermo Fisher Scientific.

The Asia Pacific poised to witness the fastest growth during the analysis period.

Some of the key players operating in the market are Agilent Technologies; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories, Inc.; Bruker Corporation; Danaher Corporation; GE Healthcare; Hitachi, Ltd.; Illumina, Inc.; Merck KGaA; Oxford Instruments plc; Qiagen N.V.; Shimadzu Corporation; Thermo Fisher Scientific, Inc.; and ZEISS International among others.